27 results
Leukemias Overview: ALL, CML, AML, APML, CLL

Acute leukemias > 20% blasts in the peripheral blood smear
Leukemias Overview ... leukemias > 20% ... mass • Rapidly rising ... Lymphadenopathy AML ... Neutrophils • Immature/Myeloblasts
Here are very large, immature myeloblasts with many nucleoli. A distincitve feature of these blasts is
large, immature myeloblasts ... acute myelogenous leukemia ... (AML) that is most ... Rods #AuerRods #AML
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Aspergillosis - IDSA ... Aspergillosis #Treatment #pharmacology ... #dosing #medications ... #IDSA #Guidelines
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of ... antimicrobials #pharmacology ... #dosing #idsa #
Basophilia - Differential Diagnosis Framework

Basophils < 1% of the total white blood cell count
Basophils function similarly
which are released during ... Chronic myeloid leukemia ... (CML) - associated ... Acute myeloid leukemia ... Acute basophilic leukemia
Dosing Nebulized Epinephrine

If racemic epinephrine is available and respiratory therapists are familiar with it, that's the
Dosing Nebulized ... eliminating 1 mg/ml ... 1000) to avoid dosing ... epinephrine” (0.1 mg/ml ... #Pharmacology #Dosing
A quick infographic describing some of the common reversal agents used by anesthesiologists, their mechanism of
mechanism of action, dosing ... Dongare, P., &amp ... Theodoraki, K., &amp ... Pharmacology of ... neuromuscular pharmacology
Spectrum of activity for systemic antifungal agents
Antifungals: 5FC, flucytosine; AMB, amphotericin B; ANI, anidulafungin; CAS, caspofungin;
, flucytosine; AMB ... fluconazole; ISA ... antibiogram #management #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... 100 cells/mm3 g/mL ... Penicilliosis #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... suspension 4–6 mL ... candida #mucosal #IDSA ... infections #HIVAIDS #pharmacology